glp 1 in obesity Weighing the risk of GLP-1 treatment older adults: Should we be concerned about sarcopenic obesity? GLP-1R Agonists for Weight Loss
Description
Understanding why this happens and applying targeted relief strategies can help you stay comfortable during your weight loss journey

Histochemistry 44: 281-290, 1975

I'm pleased to share that npj Metabolic Health and Disease is joining Communications Medicine on a new collection looking at the Therapeutic Landscape of GLP1 agonists
Ozempic, Wegovy, Rybelsus, Mounjaro, Saxenda, and other medications in this drug class were originally developed for type 2 diabetes treatment and blood sugar management, but their widespread use for weight loss dramatically expanded the number of patients exposed to these medications
